Novacyt announces initiation of coverage by Invest Securities

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces that Invest Securities, an independent investment banking and advisory group, based in Paris, has initiated research coverage of Novacyt.

Download press release